Newsroom

Explore the latest breakthroughs, insights, and stories from behind the scenes at EffRx Pharmaceuticals.
Bio 2025 in Boston
EffRx Pharmaceuticals attending the ECTS Congress taking place May 23–26, 2025, in Innsbruck, Austria
EffRx Pharmaceuticals Recognized for Sustainability Excellence with EcoVadis Silver Medal
EffRx Joins scienceindustries (the Swiss Business Association Chemistry Pharma Life Sciences)
EffRx Joins SHQA (swiss health quality association)
EffRx Attending the BIO International Convention in San Diego
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Pyridam Farma for Commercialization of BINOSTO® in Indonesia
EffRx Attending the 2024 WCO IOF-ESCEO Congress in London
EffRx is a Proud Supporter of Rare Disease Day, Taking Place on February 28
EffRx Pharmaceuticals Signs Exclusive Licensing and Distribution Agreement with Lupin for Commercialization of BINOSTO® in Vietnam & Philippines
EffRx Attending the Annual Meeting SSEDP / SGPED on 25. January 2024 in Berne
EffRx Pharmaceuticals Signs Exclusive Licensing Agreement With Radius Health To Commercialize BINOSTO® In The United States
  • | News
World Orphan Drug Alliance (WODA) Marks their First Anniversary
Abiogen Pharma Completes the Acquisition of EffRx
  • | News
EffRx Attends the WCO IOF-ESCEO Congress
  • | News
EffRx Supports the 16th Annual Rare Disease Day on 28. February 2023
  • | News
EffRx Attending the Annual Meeting SSEDP / SGPED on 26. January 2023 at the Universitäts-Kinderspital Zürich
  • | News
EffRx Attends the 1st Eastern Switzerland Symposium on Rare Diseases in St. Gallen, Switzerland
EffRx Pharmaceuticals announces the launch of Alkindi® as replacement therapy for pediatric adrenal insufficiency in Switzerland
World Orphan Drug Alliance – combining forces to reach patients with rare diseases across the globe
  • | News
EffRx Attending the 9th I-DSD Symposium 2022 in Bern, Switzerland, University Hospital Bern from 14-16th July 2022
  • | News
EffRx Featured as Member of WODA in Rare Revolution Magazine
EffRx Pharmaceuticals Signs Exclusive License Agreement with Diurnal for the Registration and Commercialization of Efmody® in Switzerland
  • | News
EffRx Exhibiting at the Austrian-Swiss Metabolic Meeting in Zürich on the 7th and 8th of April 2022
  • | News
EffRx Supports the 15th Annual Rare Disease Day on 28. February 2022
  • | News
EffRx Attending the Annual Meeting SSEDP / SGPED on 20. January 2022 in St. Gallen
  • | News
EffRx Seeks New Business Collaborations at the BIO International Convention Digital 2021
  • | News
Dr. Nathalie Véron Appointed Director Technical Operations & Qualified Person at EffRx Pharmaceuticals
  • | News
EffRx Pharmaceuticals Announces the Release of Binosto® Data in Two Publications
  • | News
EffRx Pharmaceuticals Signs Exclusive License Agreement with Dipharma SA and Launches Miglustat Dipharma in Switzerland
  • | News
World Osteoporosis Day – WOD marked on October 20th: THAT’S OSTEOPOROSIS
  • | News
The 13th international Rare Disease Day coordinated by EURORDIS will be on February 29, 2020
  • | News
EffRx Pharmaceuticals Attending the 38th Annual J.P. Morgan Healthcare Conference from January 13-16, 2020 in San Francisco
We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients
About Us
Business Development
Legal

Copyright © 2024 All rights reserved

Web Design by Solvia

We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients
Linkedin
About Us
Business Development
Legal

Copyright © 2024 All rights reserved

Web Design by Solvia

We Address Unmet Medical Needs to Improve the Health and Quality of Life of Patients

About Us

Business Development

Legal

Copyright © 2024 All rights reserved

Web Design by Solvia